ENVB (Enveric Biosciences) Earnings per share growth rate in current year

Official company branding of Enveric Biosciences (ENVB)

Year-over-year EPS growth percentages reflect the profit dynamics of Enveric Biosciences (ENVB), which is developing psilocybin-based drugs through clinic partnerships and the Psybrary system. Enveric Biosciences creates synthetic neurobiological molecules without hallucinogenic properties to combat depression. The 0.00 mark records this metric, while the patent protection of these developments is constrained by strict DEA oversight of substance circulation.

ENVB - Enveric Biosciences Inc Net earnings per share growth this year over the range 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company Enveric Biosciences (ENVB)

- price and consensus price forecast:
Stock Quotes Enveric Biosciences Inc|ENVB - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Enveric Corp|ENVB - Total Company Value
- balance sheet equity data:
Equity per Share Enveric Biosciences|ENVB - Company Net Assets|Market Value to Book Value Ratio enveric.com|ENVB - Company Total Assets
- debt and liquidity details:
Debt to Capital Enveric Biosciences|ENVB - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital enveric.com|ENVB - Company Aggregate Debts|Debts to Net Assets Enveric Corp|ENVB - Company Long-Term Debts|Company Current Liabilities Enveric Biosciences|Intermediate Coverage Ratio enveric.com
- earnings and market ratios statistics:
ENVB - Net Profit|Expected Profit Enveric Biosciences|ENVB - P/E Multiple|Market Cap to Projected Earnings Enveric Corp|ENVB - Price/Earnings to Growth Ratio|Company Value to EBITDA Enveric Corp|ENVB - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Enveric Biosciences|ENVB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months enveric.com|ENVB - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Enveric Biosciences
- company sales and revenue statistics:
ENVB - Revenue and Sales Volume|Company Expected Sales Volume Enveric Biosciences Inc|ENVB - Price-to-Revenue Ratio|Market Cap to Projected Revenue Enveric Corp
Fundamental valuation:ENVB - Enveric Biosciences Inc
Signature product of enveric.com

Enveric Biosciences (ENVB) is implementing AI robotics to accelerate the synthesis of neuropharmacological molecules, optimizing R&D costs. By analyzing the EPS growth percentage over 12 months, an investor can track the annual trend of net income per share. This metric reveals a hidden business slowdown, allowing for an objective assessment of the efficiency of the technological transition from manual research to automated asset design.

Direct competitors

Net earnings per share growth this year Indivior plc|COLL (Collegium Pharmaceutical Inc) - Earnings growth in current year|Earnings per share growth rate in current year Cronos Corp CRON|Earnings per share growth in current year Canopy Growth (CGC)|hightideinc.com - Earnings per share growth this year|Aurora Cannabis Inc. - Net earnings per share growth this year|Achieve Life Sciences Inc. - Earnings per share growth in current year|Skye Bioscience - Earnings growth in current year|Earnings per share growth rate in current year Anebulo Pharma|intercure.co (INCR) - Earnings per share growth in current year|Nutriband - Earnings per share increase in current year|NSRX (Nasus Pharma Ltd.) - Earnings growth in current year|IGC Pharma Inc (IGC) - Expected net earnings per share growth this year|Earnings growth in current year MIRA|Net earnings per share growth this year Flora Growth Inc FLGC|IM Cannabis - Net earnings per share growth this year|Earnings per share increase in current year ADIL|Artelo - Earnings growth in current year|ENSC: Earnings per share growth in current year|TTNP: Earnings growth in current year|GNLN - Expected net earnings per share growth this year|Earnings per share growth in current year InMed Pharmaceuticals|Earnings per share growth rate in current year akandacorp.com AKAN|Earnings per share growth in current year Bright Green (BGXX)|Expected net earnings per share growth this year Hempacco Co Inc.